UAE

Wegovy® pill is the first oral glucagon-like peptide-1 (GLP-1) receptor agonist approved for weight management.

The innovation aims to enhance fluid drainage, speed up recovery, and potentially reduce the need for additional corrective procedures.

Researchers aim to assess the reliability of p-Tau217 in identifying early Alzheimer’s pathology and evaluate its potential as a scalable tool for long-term monitoring.

Once fully operational, the hub is expected to enable access to treatment for more than 2.6 million patients across a population of more than 1 billion people.

The report estimates that improved interventions could help over 1.2 million adults transition out of obesity by 2031.

The initiative integrates Johnson & Johnson’s Polyphonic™ open digital ecosystem with DOH Abu Dhabi and leading technology partners, including Amazon Web Services (AWS) and NVIDIA.

The facility is built to accommodate approximately 1,000 to 1,500 healthcare professionals each year, including consultants, specialists, and early-career doctors.

MIEBO contains the active ingredient perfluorohexyloctane and is the first prescription eye drop designed to target tear evaporation directly, one of the primary causes of dry eye disease.

Regulators approved the drug as an additional therapy for patients whose blood pressure remains uncontrolled despite using standard antihypertensive medicines.

To achieve the accreditation, Fakeeh University Hospital adopted the internationally recognized “Ten Steps to Successful Breastfeeding” framework developed by WHO and UNICEF.